In vivo and in vitro anti-inflammatory activities of α-linolenic acid isolated from actinidia polygama fruits

Archives of Pharmacal Research

Volumn 30, Issue 6, 2007, Pages 708-714

  Ren, Jie ^a   Han, Eun Jung ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Actinidia polygama; Anti inflammation; COX 2; iNOS; Paw edema; PGE2; Vascular permeability; linolenic acid

Indexed keywords

EID: 34347398278     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977632     Document Type: Article

References (28)

1. Alderton, W. K., Cooper, C. E., and Knowles, R. G., Nitric oxide synthases: structure, function and inhibition. Biochem. J., 357, 593-615 (2001).
2. DeWitt, D. L. and Smith, W. L., Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Acad. Sci. U.S.A., 85, 1412-1416 (1988).
3. DeWitt, D. L. and Smith, W. L., Cloning of sheep and mouse prostaglandin endoperoxide synthases. Meth. Enzymol., 187, 469-479 (1990).
4. Dubois, R. N., Award. J., Morrow, J., Roberts, L. J., and Bishop, P. R., Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J. Clin. Invest., 93, 493-498 (1994).
5. Funk, C. D., Funk, L. B., Kennedy, M. E., Pong, A. S., and Fitzgerald, G. A., Human platelet/erthroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression and gene chromosomal assignment. FASEB J., 5, 2304-2312 (1991).
6. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R., Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem., 126, 131-138 (1982).
7. Hanelt, M., Gareis, M., and Kollarcaik, B., Cytotoxity of mycotoxins evaluated by the MTT-cell culture assay. Mycopathologia, 128, 167-174 (1994).
8. Hewett, J. A. and Roth, R. A., Hepatic and extrahepatic pathobiology of bacterial lipopoly-saccharides. Pharmacol. Rev., 45, 381-509 (1993).
9. Kashimoto, T. and Kanazawa, U., Vegetable oils and fats. III. Nippon Kagaku Zasshi, 76, 664-667 (1955).
10. Kim, Y. K., Kang, H. J., Lee, K. T., Choi, J. G., and Chung, S. H., Anti-inflammation activity of Actinidia polygama. Arch. Pharm. Res., 26, 1061-1066 (2003).
11. Kubes, P. and Mccafferty, D. M., Nitric oxide and intestinal inflammation. Am. J. Med., 109, 150°©158 (2000).
12. Liu, R. H. and Hotchkiss, J. H., Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res., 339, 73-89 (1995).
13. MacMicking, J., Xie, Q. W., and Nathan, C., Nitric oxide and macrophage function. Annu. Rev. Immunol., 15, 323-350 (1997).
14. Mercurio, F. and Manning, A. M., Multiple signals converging on NF-kappaB. Curr. Opin. Cell Biol., 11, 226-232 (1999).
15. Merlie, J. P., Fagan, D., Mudd, J., and Needleman, P., Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J. Biol. Chem., 263, 3550-3553 (1988).
16. Moncada, S., Palmer, R. M., and Higgs, E. A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142 (1991).
17. O'Banion, M. K., Winn, V. D., and Young, D. A., cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A., 89, 4888-4892 (1992).
18. O'Neill, G. P. and Ford-Hutchinson, A. W., Expression of messenger RNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett., 330, 156-160 (1993).
19. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., and Isakson, P., Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A., 91, 12013-12017 (1994).
20. Singh, S. and Majumdar, D. K., Evaluation of anti-inflammatory activity of fatty acids of Ocimum sanctum fixed oil. Indian J. Exp. Biol., 35, 380-383 (1997).
21. Smith, W. L., Meada, E. A., and Dewitt, D. L., Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. ann. NY. Acad. Sci., 744, 50-57 (1994).
22. Surh, Y. J., Chun, K. S., Cha, H. H., han, S. S., Keum, Y. S., Park, K. K., and Lee, S. S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOX through suppression of NF-kappa B activation. Mutat. Res., 480-481, 243-268 (2001).
23. Watson, W. H., Zhao, Y., and Chawla, R. K., S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for the tumour necrosis factor-α. Biochem. J., 342, 21-25 (1999).
24. Weisz, A., Cicatiello, L., and Esumi, H., Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine. Biochem. J., 316, 209-215 (1996).
25. Winter, C. A., Risley, E. A., and Nuss, G. W., Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med., 111, 544-547 (1962).
26. Whittle, B. A., The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics. Brit. J. Pharmacol., 22, 246-253 (1964).
27. Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., and Simmons. D. L., Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A., 88, 2692-2696 (1991).
28. Yamamoto, Y. and Gaynor, R. B., Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest., 107, 135-142 (2001).